introduct
etiolog
diagnosi
infecti
enceph
often
establish
hour
onset
aim
review
exist
literatur
data
provid
manag
guidelin
method
perform
literatur
search
pubm
use
filter
sinc
human
adult
english
french
clinic
trialreviewguidelin
also
use
mesh
search
term
encephalitistherapi
encephalitisdiagnosi
result
mesh
search
term
encephalitistherapi
encephalitisdiagnosi
retriev
articl
respect
search
term
enceph
corticosteroid
identifi
articl
enceph
doxycyclin
without
abovement
filter
identifi
articl
total
articl
includ
analysi
discuss
etiolog
investig
must
focu
recent
travel
anim
exposur
age
immunodefici
neurolog
damag
characterist
potenti
extraneurolog
sign
interest
diagnosi
enceph
specif
treatment
also
discontinu
empir
treatment
initi
prescrib
physician
must
consid
search
autoimmun
enceph
introduct
labsenc
de
diagnost
heur
de
prise
en
charg
dune
infectieus
est
nou
avon
voulu
fair
le
point
de
la
existant
avant
de
donner
de
recommand
de
prise
en
charg
dan
pubm
nou
avon
le
filtr
sinc
human
adult
english
french
et
clinic
trialreviewguidelin
ainsi
que
le
mot
mesh
encephalitistherapi
et
encephalitisdiagnosi
le
mot
mesh
encephalitistherapi
et
encephalitisdiagnosi
aboutiss
respectiv
et
articl
le
mot
enceph
corticosteroid
aboutiss
articl
et
enceph
doxycyclin
san
le
filtr
articl
au
total
articl
ont
retenu
p
fillatr
et
al
et
maladi
infectieus
discuss
le
recherch
doivent
par
le
notion
de
voyag
dexposit
animal
ou
ainsi
que
par
le
de
latteint
neurologiqu
et
le
sign
extraneurologiqu
du
diagnost
de
qui
ne
dispos
pa
de
traitement
est
le
traitement
probabilist
initial
mi
en
rout
le
autoimmun
doivent
third
day
enceph
patient
manag
firstlin
diagnost
test
result
may
lead
etiolog
identif
herp
simplex
viru
hsv
varicella
zoster
viru
vzv
enteroviru
pcr
test
csf
blood
cultur
neg
quit
frequent
even
extens
standard
etiolog
investig
caus
agent
document
case
metabol
toxic
encephalopathi
diagnosi
must
reconsid
csf
analysi
normal
aim
literatur
review
better
character
clinic
present
infecti
enceph
understand
etiolog
test
perform
improv
diagnost
therapeut
manag
patient
assum
amoxicillin
acyclovir
treatment
prescrib
start
patient
manag
identifi
articl
respect
use
pubm
filter
sinc
human
adult
english
french
clinic
trialreviewguidelin
mesh
search
term
encephalitistherapi
encephalitisdiagnosi
also
took
consider
articl
mention
select
articl
without
use
filter
public
date
identifi
articl
search
term
enceph
corticosteroid
articl
enceph
doxycyclin
without
use
abovement
filter
includ
total
articl
literatur
analysi
hsv
enceph
frequent
caus
viral
enceph
therapeut
delay
impact
vital
function
prognos
thu
recommend
initi
empir
treatment
acyclovir
patient
present
sign
symptom
enceph
receiv
result
csf
hsv
pcr
test
typic
clinic
sign
symptom
describ
retrospect
studi
includ
fever
case
conscious
disord
observ
case
mean
glasgow
score
minor
patient
glasgow
score
raschila
studi
disorient
observ
case
behavior
disord
languag
disord
seizur
focal
neurolog
disord
csf
analysi
infecti
enceph
patient
reveal
lymphocyt
mening
median
csf
cell
count
nucleat
cell
nc
mm
lymphocyt
neutrophil
neutrophil
predomin
rare
patient
neutrophil
maximum
csf
cell
count
ncmm
patient
csf
protein
level
moder
high
gl
csf
protein
level
gl
observ
patient
radiolog
find
describ
studi
patient
present
hsv
enceph
tempor
lesion
patient
frontotempor
lesion
patient
lesion
also
describ
patient
occipit
present
extratempor
present
seem
mainli
report
immunocompromis
patient
although
document
case
report
immunocompet
patient
patient
normal
mri
result
author
recent
retrospect
studi
observ
initi
bilater
lesion
extratempor
lesion
mri
associ
lower
risk
hsv
enceph
etiolog
respect
csf
hsv
pcr
test
current
refer
diagnost
method
hsv
enceph
sensit
compar
brain
biopsi
howev
import
keep
mind
pcr
result
may
neg
first
day
author
retrospect
studi
children
present
hsv
enceph
report
neg
result
children
day
diseas
evolut
diagnost
sensit
day
day
respect
neg
result
significantli
associ
lower
csf
protein
level
absenc
associ
mening
cutoff
valu
leukocytesmm
studi
author
anoth
studi
patient
present
histori
hsv
enceph
observ
three
patient
initi
neg
csf
hsv
pcr
turn
posit
day
later
even
initi
acyclovir
treatment
neg
pcr
observ
patient
present
without
associ
mening
author
studi
report
csf
cell
count
three
neg
csf
pcr
test
perform
first
lumbar
punctur
leukocytesmm
respect
studi
report
neg
pcr
test
perform
earli
csf
sampl
collect
onset
clinic
sign
howev
note
rare
author
french
prospect
studi
enceph
patient
observ
patient
present
hsv
enceph
initi
posit
csf
hsv
pcr
even
though
perform
within
two
day
clinic
sign
onset
patient
csf
hsv
pcr
usual
remain
posit
day
follow
antivir
treatment
initi
anoth
studi
show
pcr
result
remain
posit
day
day
treatment
csf
sampl
day
day
csf
sampl
beyond
day
csf
sampl
nevertheless
old
studi
patient
whose
pcr
result
remain
posit
first
week
often
treat
vidarabin
acyclovir
author
report
patient
remain
longer
vidarabin
treatment
obtain
neg
pcr
result
benefit
csf
hsv
pcr
depend
like
diagnost
test
pretest
probabl
probabl
calcul
base
radiolog
clinic
present
csf
analysi
thu
posttest
probabl
calcul
bayesian
statisticsof
obtain
hsv
enceph
diagnosi
despit
neg
pcr
differ
patient
present
confus
fever
admit
emerg
depart
receiv
acyclovir
empir
treatment
pretest
probabl
patient
present
typic
sign
symptom
pretest
probabl
diagnosi
may
reason
rule
neg
pcr
first
type
patient
posttest
probabl
second
type
patient
posttest
probabl
must
lead
investig
rule
hsv
enceph
diagnosi
vzv
enceph
report
second
third
caus
enceph
recent
french
anglosaxon
studi
vzv
enceph
probabl
underdiagnos
especi
may
occur
without
associ
skin
lesion
vzv
reportedli
respons
enceph
well
central
nervou
system
vascul
infarct
twothird
patient
present
vzv
central
nervou
system
vascul
also
present
moder
lymphocyt
pleocytosi
ncmm
moder
high
csf
protein
level
normal
csf
glucos
level
sensit
csf
vzv
pcr
moder
satisfactori
result
may
neg
depend
type
cn
lesion
well
first
day
follow
symptom
onset
although
less
document
hsv
author
literatur
review
patient
present
enceph
without
associ
vascul
observ
patient
diagnos
use
vzv
pcr
four
remain
patient
present
previous
present
vesicular
rash
anoth
studi
report
posit
csf
vzv
pcr
two
three
enceph
patient
patient
present
meningoradicul
shingl
howev
author
literatur
review
vzv
central
nervou
system
vascul
observ
vzv
pcr
less
sensit
intrathec
secret
antivzv
antibodi
test
p
pcr
test
posit
patient
test
posit
intrathec
secret
author
anoth
literatur
review
report
result
sensit
rang
sensit
differ
depend
pathophysiolog
enceph
pcr
test
may
posit
intrathec
secret
immunoglobulin
convers
vzv
vascul
onset
observ
week
viral
infect
stage
intrathec
secret
immunoglobulin
remain
posit
note
studi
report
clear
superior
detect
sensit
antivzv
antibodi
versu
vzv
pcr
perform
team
nagel
gilden
colorado
although
american
guidelin
recommend
antivzv
antibodi
detect
test
consensu
method
perform
analysi
interpret
standard
crossreact
also
occur
antihsv
antivzv
antibodi
detect
test
detect
test
antibodi
vzv
glycoprotein
e
ge
seem
specif
avail
routin
practic
author
french
multicent
prospect
studi
enceph
report
listeria
monocytogen
second
bacteri
caus
enceph
mycobacterium
tuberculosi
howev
listeria
monocytogen
associ
highest
lethal
patient
present
sever
comorbid
cn
damag
especi
brainstem
damag
frequent
local
invas
listeriosi
adult
except
pregnant
women
risk
listeria
monocytogen
invas
infect
exponenti
increas
age
occur
specif
patient
present
sever
immunodefici
pregnant
women
author
studi
listeriosi
case
patient
document
franc
observ
incid
age
age
group
patient
age
year
highest
incid
observ
patient
present
chronic
lymphocyt
leukemia
csf
analysi
reveal
mening
ncmm
usual
mix
show
lymphocyt
predomin
high
csf
protein
level
gl
low
csf
glucos
level
case
author
literatur
review
rhombenceph
patient
report
sensit
gramstain
microscop
examin
cultur
respect
sensit
case
mening
blood
cultur
posit
twothird
case
sensit
listeria
pcr
depend
primer
use
author
studi
report
pcr
test
target
iap
gene
posit
listeria
case
confirm
cultur
allow
identifi
three
seven
mening
case
neg
cultur
primer
associ
lack
specif
four
posit
pcr
test
obtain
csf
cultur
posit
haemophilu
influenza
sinc
rtpcr
amplifi
hli
gene
encod
l
monocytogen
listeriolysin
csf
develop
test
csf
sampl
patient
suspect
l
monocytogen
cn
infect
addit
nine
case
confirm
cultur
pcr
also
highli
posit
five
patient
despit
neg
cultur
receiv
antibiot
within
day
lumbar
punctur
specif
primer
seem
much
better
fals
posit
result
report
howev
sensit
excel
pcr
test
neg
patient
present
document
infect
associ
bacteremia
antillo
antibodi
seroconvers
main
risk
factor
tuberculosi
prolong
stay
endem
area
chronic
alcohol
solid
cancer
prolong
corticoid
therapi
antitnf
treatment
thwait
develop
algorithm
differenti
bacteri
mening
tubercul
mening
base
clinic
age
rapid
clinic
evolut
paraclin
criteria
csf
cell
count
percentag
neutrophil
elev
white
blood
cell
count
sensit
specif
algorithm
sinc
prospect
evalu
patient
present
mening
low
csf
glucos
level
associ
excel
neg
predict
valu
thu
allow
reason
rule
diagnosi
score
note
csf
ncmm
neutrophil
alreadi
associ
score
respect
algorithm
valid
southeast
asia
preval
tubercul
mening
high
evalu
countri
lower
preval
algorithm
seem
discrimin
countri
high
preval
hiv
trial
antituberculosi
treatment
recommend
clinic
sign
symptom
paraclin
examin
match
treatment
initi
diagnost
confirm
especi
often
delay
due
time
requir
cultur
delay
treatment
highli
associ
poor
prognosi
especi
elderli
patient
patient
present
initi
conscious
disord
hydrocephalu
cerebr
ischemia
empir
antituberculosi
treatment
initi
cultur
remain
neg
british
guidelin
recommend
continu
antituberculosi
treatment
absenc
etiolog
grade
biii
guidelin
specifi
decis
continu
discontinu
trial
treatment
base
improv
patient
condit
lack
antituberculosi
drug
grade
biii
data
csf
evolut
antituberculosi
treatment
scarc
quantiti
lymphocyt
csf
protein
level
seem
take
much
longer
normal
csf
glucos
level
antituberculosi
treatment
must
combin
system
corticoid
therapi
author
metaanalysi
seven
random
studi
patient
report
reduc
mortal
patient
receiv
corticoid
rel
risk
better
function
prognosi
corticoid
therapi
thu
recommend
guidelin
grade
ai
nonhivinfect
patient
diagnost
test
sensit
data
extrapol
avail
data
tubercul
mening
studi
conduct
tubercul
enceph
author
prospect
studi
tubercul
mening
adult
patient
perform
vietnam
manag
obtain
microbiolog
diagnosi
patient
microscop
examin
csf
cultur
posit
case
respect
sensit
csf
microscop
examin
influenc
number
sampl
evalu
per
patient
sensit
rang
one
three
csf
sampl
analyz
despit
antituberculosi
treatment
initi
volum
csf
avail
ml
best
examin
csf
sediment
author
larg
european
retrospect
studi
countri
patient
present
central
nervou
system
tuberculosi
select
base
posit
microscop
examin
ziehlneelsen
stain
ii
andor
posit
csf
cultur
lowenstein
medium
iii
andor
posit
bk
pcr
observ
csf
cytolog
yield
ncmm
predomin
lymphocyt
csf
protein
level
gl
csf
glucos
levelglycemia
ratio
cultur
sensit
lowenstein
medium
sensit
microscop
examin
sever
author
suggest
use
csf
adenosin
deaminas
ada
titrat
criterion
discrimin
tubercul
mening
bacteri
mening
type
despit
low
level
evid
author
metaanalysi
perform
report
sensit
specif
ada
titrat
diagnosi
central
nervou
system
tuberculosi
posit
neg
likelihood
ratio
respect
anoth
studi
report
lower
sensit
ada
titrat
nevertheless
recent
european
studi
report
posit
ada
routin
practic
case
benefit
test
thu
limit
author
studi
south
african
patient
major
hivinfect
individu
present
mening
observ
quantit
xpert
mtbrif
pcr
versu
cultur
andor
amplicor
pcr
associ
better
sensit
clinic
score
csf
microscop
examin
gram
auramin
stain
versu
respect
p
better
sensit
observ
csf
sampl
previous
centrifug
vs
requir
ml
csf
instead
ml
south
africa
endem
countri
tuberculosi
ppv
npv
xpert
mtbrif
test
author
metaanalysi
publish
includ
studi
observ
sensit
specif
xpert
mtbrif
test
csf
compar
cultur
respect
author
multicent
european
studi
observ
sensit
bk
pcr
intub
report
good
result
posit
result
test
sensit
author
european
studi
suggest
follow
explan
lower
diagnost
sensit
techniqu
quantiti
tubercul
bacilli
studi
sampl
probabl
much
signific
southeast
asia
longer
time
clinic
sign
onset
hospit
admiss
evidencebas
data
support
benefit
system
corticoid
therapi
enceph
type
author
clinic
case
report
mention
benefit
corticoid
patient
present
conscious
disord
due
nonspecif
reduct
cerebr
edema
corticoid
therapi
howev
import
patient
present
adem
autoimmun
enceph
patient
present
associ
vascul
said
patient
present
tubercul
mening
combin
enceph
hsv
enceph
nonrandom
studi
highlight
benefit
adjuv
corticoid
therapi
acyclovir
treatment
definit
role
could
clarifi
lack
inclus
initi
random
prospect
studi
anoth
intern
random
studi
current
design
solomon
unpublish
data
studi
evalu
efficaci
treatment
empir
administ
nevertheless
diagnost
difficulti
enceph
caus
intracellular
bacteria
doxycyclin
may
use
thank
broadspectrum
activ
bacteria
author
clinic
case
report
shortterm
studi
call
mind
molecul
effect
rickettsia
coxiella
burnetii
mycoplasma
typhusassoci
enceph
although
doxycyclin
firstlin
option
includ
therapeut
armamentarium
brucella
bartonella
hensela
tropheryma
whipplei
ehrlichia
enceph
even
lyme
neuroborreliosi
toxoplasmosi
secondlin
context
etiolog
may
need
investig
depend
exposur
patient
characterist
clinic
present
infect
especi
diagnos
howev
enceph
present
stage
primari
infect
rare
author
studi
patient
present
hiv
primari
infect
neurolog
damag
observ
patient
peripher
neuropathi
eight
isol
lymphocyt
mening
two
acut
enceph
report
central
neurolog
damag
includ
enceph
adem
sometim
lifethreaten
patient
present
neurolog
symptom
primari
infect
stage
seem
contract
aid
rapidli
even
combin
hiv
serolog
test
detect
antibodi
lack
sensit
first
day
primari
infect
test
repeat
plasma
rnahiv
search
patient
present
sever
neurolog
symptom
test
posit
plasma
viral
load
must
complet
csf
viral
load
incid
syphili
consider
increas
franc
sinc
especi
men
sex
men
neurosyphili
may
present
enceph
csf
analysi
usual
indic
pleocytosi
may
normal
case
especi
tertiari
syphili
tabe
csf
protein
level
moder
high
normal
meningovascular
syphili
diagnosi
neurosyphili
reli
posit
serum
serolog
activ
syphili
associ
least
two
csf
abnorm
among
follow
posit
vener
diseas
research
laboratori
vdrl
mening
nc
high
csf
protein
level
enteroviru
frequent
caus
mening
children
adult
usual
associ
enceph
two
situat
howev
distinguish
one
anoth
regardless
context
enteroviru
csf
pcr
test
posit
patient
present
enceph
sampl
sent
enteroviru
nation
refer
center
better
character
strain
author
studi
patient
report
enteroviru
ev
csf
pcr
amplicor
test
roch
better
sensit
cell
cultur
vs
rapid
result
avail
hour
also
advantag
compar
cultur
day
author
retrospect
studi
patient
observ
sensit
ev
pcr
diagnosi
ev
mening
csf
stool
sampl
respect
sensit
csf
pcr
decreas
two
day
diseas
onset
sensit
stool
pcr
remain
high
day
diseas
onset
persist
posit
stool
pcr
report
studi
absenc
csf
pcr
analysi
come
back
neg
posit
ev
pcr
stool
throat
sampl
patient
present
neurolog
symptom
must
lead
physician
consid
ev
diagnosi
two
etiolog
caus
agent
rare
detect
cn
must
consid
diagnost
confirm
may
obtain
pcr
nasopharyng
secret
blood
serolog
absenc
direct
document
csf
sampl
indic
postinfecti
impair
like
adem
pneumonia
enceph
mainli
report
children
author
prospect
studi
patient
address
california
enceph
project
enceph
without
etiolog
diagnosi
observ
sign
recent
pneumonia
infect
serum
igm
seroconvers
csf
respiratori
secret
pcr
posit
pneumonia
patient
children
diagnosi
reli
serolog
test
pediatr
case
patient
serum
igm
seroconvers
among
adult
pediatr
patient
pneumonia
pcr
csf
respiratori
secret
posit
case
respect
larg
review
mycoplasma
pneumonia
enceph
csf
abnorm
report
patient
usual
ncmm
lymphocyt
predomin
case
high
csf
protein
level
observ
case
csf
glucos
level
normal
limit
current
diagnost
test
persist
posit
serum
igm
respiratori
pcr
test
sever
month
initi
infect
thu
call
question
respons
pneumonia
case
document
reli
one
test
compar
seroconvers
csf
antibodi
detect
physician
may
look
influenza
viru
endem
period
author
literatur
review
influenza
viru
neurolog
manifest
report
posit
csf
pleocytosi
observ
case
csf
protein
level
csf
glucos
level
usual
within
normal
valu
although
significantli
high
csf
protein
level
report
detect
influenza
bspecif
rna
fragment
csf
sampl
brain
biopsi
plate
rtpcr
document
enceph
case
earli
day
follow
infect
onset
howev
although
studi
report
posit
influenza
csf
pcr
test
five
posit
case
six
patient
present
encephalopathi
influenza
viru
rare
detect
csf
sampl
studi
viru
detect
cultur
immunostain
techniqu
report
autopsi
case
diffus
edema
without
inflammatori
infiltr
specif
cytopathogen
effect
observ
physician
must
consid
ebv
children
present
acut
enceph
without
etiolog
diagnosi
clinic
sign
symptom
vari
includ
fever
cephalgia
seizur
behavior
disord
cerebellar
syndrom
rhombenceph
case
young
adult
also
report
diagnosi
reli
plasma
serolog
molecular
biolog
techniqu
serum
csf
pcr
author
studi
report
sensit
molecular
biolog
techniqu
mani
coinfect
also
report
author
studi
patient
posit
ebv
csf
pcr
observ
anoth
infect
measl
mump
rubella
diagnosi
reli
serolog
detect
acut
infect
possibl
confirm
csf
pcr
neg
case
postinfecti
enceph
measl
respons
three
type
neurolog
complic
postinfecti
acut
enceph
usual
occur
day
rash
onset
preval
case
patient
per
measl
case
present
associ
adem
describ
follow
chapter
viru
never
detect
csf
sampl
postinfecti
inflamm
focal
neurolog
disord
seizur
fever
usual
report
infect
associ
poor
prognosi
patient
die
sever
sequela
two
present
enceph
acut
inclus
bodi
enceph
occur
highli
immunocompromis
patient
five
week
six
month
rash
onset
scleros
subacut
panenceph
occur
sever
month
rash
onset
link
viru
persist
within
brain
mump
viru
infect
present
parotid
mening
enceph
case
respect
clinic
sign
symptom
includ
fever
seizur
conscious
disord
prognosi
usual
favor
lethal
low
morbid
rate
csf
analysi
reveal
predominantli
lymphocyt
pleocytosi
normal
slightli
elev
csf
protein
level
usual
normal
csf
glucos
level
approxim
rubella
patient
also
present
enceph
clinic
sign
symptom
nonspecif
lethal
could
reach
clinic
sign
symptom
usual
selflimit
week
lead
sequela
diagnosi
reli
plasma
csf
serolog
cmv
enceph
almost
exclus
occur
highli
immunocompromis
patient
author
literatur
review
case
report
publish
report
patient
hivinfect
present
anoth
form
immunodefici
immunocompet
mani
document
case
cmv
enceph
report
patient
underw
allogen
hematopoiet
stem
cell
ahsc
transplant
rare
case
also
observ
immunocompet
patient
diagnosi
reli
cmv
csf
pcr
initi
treatment
base
combin
foscavir
ganciclovir
class
iv
evid
dual
combin
therapi
seem
associ
better
prognosi
cmv
enceph
patient
diagnosi
enceph
consid
without
first
rule
possibl
viral
genom
integr
within
host
chromosom
defin
high
concentr
viral
dna
serum
log
copiesml
whole
blood
log
copiesml
may
lead
wrongli
interpret
presenc
dna
csf
case
chromosom
integr
part
viral
genom
massiv
replic
usual
host
dna
replic
occur
without
trigger
infecti
viru
product
without
associ
symptom
anoth
diagnost
mean
chromosom
integr
consist
look
genom
tissu
devoid
live
cell
hair
hair
follicl
nail
true
enceph
mainli
occur
patient
underw
allogen
hematopoiet
stem
cell
ahsc
transplant
patient
detect
viral
load
far
lower
patient
chromosom
integr
detect
csf
cytolog
analysi
may
normal
main
subtyp
associ
enceph
predominantli
limbic
present
presenc
csf
immunocompet
patient
therefor
rather
indic
chromosom
integr
true
infect
true
enceph
treatment
ganciclovir
foscavir
chromosom
integr
treat
sever
studi
nonhivinfect
patient
present
progress
multifoc
leukoencephalopathi
pml
conduct
author
report
csf
analysi
usual
reveal
normal
cytolog
rare
case
highli
moder
pleocytosi
minor
elev
csf
protein
level
gl
normal
cf
glucos
level
jc
csf
pcr
test
vari
degre
sensit
depend
techniqu
use
type
primer
prior
centrifug
csf
author
studi
nonhivinfect
patient
present
histolog
confirm
pml
observ
csf
pcr
posit
patient
csf
pcr
neg
diagnost
confirm
reli
genom
detect
brain
biopsi
histolog
examin
identifi
oligodendrocyt
destruct
nuclear
inclus
jc
viru
electron
microscopi
multifoc
loss
myelin
plasma
pcr
test
may
posit
jc
viru
diagnost
confirm
requir
histolog
examin
perform
look
typic
lesion
pml
featur
observ
patient
includ
deceas
patient
effect
specif
treatment
substanti
decreas
immunosuppress
drug
dose
may
impact
function
vital
prognosi
author
french
multicent
prospect
studi
report
case
cryptococcosi
observ
nonhivinfect
patient
patient
present
hemopathi
undergon
solid
organ
transplant
present
solid
cancer
variou
risk
factor
sarcoidosi
diabet
cirrhosi
corticoid
therapi
hypogammaglobulinemia
underli
immunodefici
identifi
nine
patient
central
nervou
system
cryptococcosi
case
report
author
immunocompet
patient
sign
symptom
nonspecif
nonhivinfect
patient
fever
observ
patient
conscious
disord
sign
focal
mening
author
observ
csf
cell
count
nonhivinfect
patient
present
cn
cryptococcosi
higher
p
median
ncmm
moder
elev
csf
protein
level
gl
frequent
low
csf
glucos
level
mean
csfblood
ratio
diagnosi
reli
posit
microscop
examin
csf
stain
india
ink
detect
cryptococc
antigen
csf
analysi
cultur
sensit
techniqu
serum
antigen
test
posit
case
thu
indic
dissemin
fungal
infect
plasma
igg
serolog
must
prescrib
immunodefici
associ
risk
cyst
reactiv
brain
damag
diagnosi
reli
immunodefici
context
mri
find
rare
enceph
present
without
abscess
report
toxoplamosi
csf
pcr
sensit
specif
basi
recent
travel
criteria
describ
epidemiolog
section
follow
etiolog
must
investig
trypanosomiasi
cerebr
malaria
must
consid
patient
travel
back
endem
area
even
consid
true
enceph
present
sever
arbovirus
must
investig
depend
geograph
area
context
serolog
diagnost
tool
flaviviru
especi
dengu
murray
valley
enceph
yellow
fever
tickborn
enceph
saint
loui
west
nile
virus
phleboviru
toscana
viru
sandfli
fever
napl
sandfli
fever
sicilian
virus
poorli
specif
seroneutr
must
therefor
perform
refer
laboratori
use
socal
plaquereduct
neutral
test
prnt
techniqu
crossreact
speci
similarli
prior
vaccin
flaviviru
tbe
japanes
enceph
yellow
fever
may
compromis
serolog
interpret
detect
intrathec
immunoglobulin
secret
use
prnt
techniqu
may
thu
requir
elisa
detect
method
igm
csf
blood
sampl
patient
suspect
japanes
enceph
sensit
studi
patient
antibodi
time
hospit
admiss
almost
patient
antibodi
three
day
diseas
onset
pcr
test
may
also
perform
csf
sampl
techniqu
profit
first
four
day
diseas
onset
author
thai
studi
patient
present
serolog
confirm
japanes
enceph
observ
frequenc
specif
igm
detect
use
elisa
test
serum
day
day
day
follow
first
symptom
onset
csf
day
beyond
day
symptom
onset
diagnos
japanes
enceph
igm
detect
csf
sampl
therefor
sensit
method
matter
initi
symptom
appear
serolog
diagnosi
reliabl
nine
day
diseas
onset
author
literatur
review
observ
presenc
antijapanes
enceph
viru
igm
antibodi
csf
sampl
day
diseas
onset
sensit
csf
analysi
often
reveal
pleocytosi
usual
ncmm
predomin
neutrophil
initi
phase
lymphocyt
later
stage
fluid
often
hemorrhag
high
csf
protein
level
case
csf
igm
appear
within
day
cn
impair
onset
disappear
week
igg
appear
csf
rare
case
csf
pcr
test
may
posit
earli
phase
mening
combin
enceph
rare
chronic
present
benefit
therefor
limit
csf
analysi
patient
present
cn
impair
relat
wnv
reveal
pleocytosi
case
usual
ncmm
moder
high
csf
protein
level
normal
csf
glucos
level
csf
often
hemat
rbcmm
case
diagnosi
reli
antiwnv
antibodi
detect
igg
igm
csf
blood
sampl
detect
posit
igm
csf
sampl
pathognomon
cn
infect
antibodi
cross
bloodbrain
barrier
igm
sensit
csf
good
report
sampl
day
usual
neg
blood
first
day
symptom
onset
antibodi
remain
csf
long
time
end
infect
two
month
patient
may
even
stay
longer
specif
igm
detect
csf
sampl
three
patient
day
follow
wnv
enceph
viral
genom
detect
pcr
may
also
perform
sensit
lower
csf
plasma
combin
plasma
pcr
serolog
test
help
improv
diagnost
sensit
acut
phase
infect
show
studi
plasma
pcr
alon
sensit
igm
serolog
alon
sensit
techniqu
combin
sensit
dvrelat
neurolog
damag
vari
may
lifethreaten
author
retrospect
studi
patient
die
dv
infect
observ
patient
cn
impair
enceph
case
mening
combin
enceph
mening
diagnosi
confirm
csf
rtpcr
seven
patient
csf
igm
detect
test
patient
csf
antigen
detect
test
patient
author
vietnames
prospect
studi
patient
present
dvrelat
neurolog
manifest
includ
enceph
patient
observ
three
patient
csf
set
pressur
cm
h
three
patient
pleocytosi
seven
high
csf
protein
level
gl
patient
present
low
csf
glucos
level
baselin
discharg
serum
serolog
led
establish
diagnosi
patient
respect
diagnosi
base
csf
serolog
six
patient
confirm
viral
cultur
serum
seven
patient
csf
viral
cultur
two
patient
final
diagnosi
establish
serum
pcr
csf
pcr
five
three
patient
respect
guinea
java
island
csf
analysi
usual
reveal
pleocytosi
rather
lymphocyt
one
diagnosi
reli
detect
viral
genom
pcr
virem
phase
last
less
day
inocul
csf
pcr
test
usual
neg
igm
appear
serum
day
day
use
serolog
test
crossreact
observ
flaviviru
even
postyellow
fever
japanes
enceph
vaccin
immun
powassan
viru
pv
diagnosi
reli
detect
serum
csf
specif
igm
confirm
usual
obtain
prnt
csf
rtpcr
may
also
help
confirm
diagnosi
csf
analysi
usual
reveal
lymphocyt
pleocytosi
normal
csf
glucos
level
moder
high
csf
protein
level
gl
pcr
test
sensit
igm
detect
cultur
realtim
pcr
techniqu
develop
use
diagnosi
toscana
viru
infect
regardless
nativ
andor
import
natur
viru
new
lineag
toscana
viru
differ
strain
found
itali
inde
observ
spain
cell
cultur
seem
poorli
sensit
detect
viru
isol
csf
sampl
plate
onto
vero
cell
pcr
test
posit
toscana
viru
variou
bunyavirida
virus
may
consid
multiplex
rtpcr
abl
target
preserv
common
area
within
heterogen
famili
bunyavirida
virus
includ
member
techniqu
valid
detect
bunyavirus
respons
enceph
california
enceph
viru
la
cross
viru
rift
valley
fever
viru
sandfli
fever
napl
viru
toscana
viru
sandfli
fever
sicilian
viru
common
diagnost
tool
igm
detect
test
csf
sampl
la
cross
viru
detect
antila
cross
viru
igm
elisa
test
enough
confirm
enceph
diagnosi
powassan
viru
infect
diagnosi
base
detect
serum
csf
specif
igm
confirm
usual
obtain
prnt
csf
rtpcr
specif
etiolog
must
consid
depend
type
exposur
rare
etiolog
detail
tabl
freeliv
amoeba
enceph
report
immunocompet
immunocompromis
individu
clinic
sign
nonspecif
evolut
usual
subacut
concomit
skin
lesion
report
case
possibl
document
skin
lesion
case
patient
report
northern
latin
america
anecdot
case
patient
report
asia
australia
europ
studi
report
case
amoeb
enceph
caus
balamuthia
mandrillari
acanthamoeba
also
report
pleocytosi
usual
lymphocyt
high
csf
protein
level
often
gl
low
csf
glucos
level
serolog
help
establish
diagnosi
limit
result
could
neg
immunocompromis
patient
case
confirm
brain
biopsi
serolog
neg
besid
expos
patient
serolog
could
posit
even
though
sign
amoeb
enceph
observ
serolog
cutoff
valu
diagnosi
usual
hard
establish
must
lead
stereotact
brain
biopsi
microscop
examin
hematoxylin
eosin
stain
case
posit
serolog
test
look
cyst
trophozoit
form
diagnost
confirm
may
done
pcr
cultur
csf
rna
pcr
test
brain
biopsi
pcr
combin
diagnos
freeliv
amoeba
enceph
sensit
excel
case
posit
pcr
test
least
one
two
sampl
typic
brain
lesion
observ
balamuthia
acanthamoeba
amoeb
enceph
patient
granulomat
amoeb
enceph
although
absenc
granuloma
histolog
examin
rule
diagnosi
amoeba
usual
look
like
ring
locat
perivascular
space
brain
vessel
naegleria
fowleri
amoeba
respons
mening
combin
enceph
immunocompet
patient
follow
fresh
water
swim
clinic
sign
symptom
similar
fulmin
usual
fatal
hemorrhag
enceph
case
report
unit
state
south
america
southeast
asia
africa
well
turkey
itali
diagnosi
reli
csf
analysi
reveal
pleocytosi
high
csf
protein
level
may
sometim
gl
microscop
examin
may
yield
freeliv
amoeba
diagnost
confirm
naegleria
fowleri
infect
may
done
immunofluoresc
techniqu
antin
fowleri
antibodi
molecular
biolog
use
specif
pcr
test
autoimmun
enceph
paraneoplast
enceph
caus
presenc
antibodi
target
cn
antigen
may
common
antigen
express
tumor
tissu
clinic
present
nonspecif
may
mimic
symptom
infecti
enceph
although
clinic
present
antinmdar
antibodi
enceph
specif
present
knowledg
topic
rapidli
grow
refer
center
need
work
togeth
respect
new
specif
present
new
antibodi
regularli
report
antigaba
receptor
antibodi
enceph
respons
statu
epilepticu
report
immunoglobulin
class
autoantibodi
target
neuron
membran
receptor
associ
specif
clinic
present
antibodi
associ
autoimmun
enceph
igg
class
detect
iga
igm
antibodi
target
antigen
poor
diagnost
clinic
signific
instanc
although
igg
antibodi
nmdar
specif
antindmar
enceph
antinmethyldaspart
receptor
healthi
subject
antinmdar
serum
iga
igm
antibodi
csf
detect
antibodi
therefor
fundament
except
rare
case
antibodi
enceph
case
associ
presenc
csf
antibodi
relev
antibodi
absent
serum
also
frequent
detect
csf
antindmar
antibodi
enceph
instanc
csf
antibodi
level
better
correl
clinic
evolut
serum
concentr
detect
techniqu
serum
antibodi
induc
import
background
nois
hard
interpret
may
trigger
fals
posit
result
howev
background
nois
insignific
csf
antinmdar
antibodi
enceph
describ
present
articl
frequent
best
character
type
enceph
antinmdar
enceph
typic
clinic
sign
symptom
combin
psychiatr
disord
seizur
conscious
disord
author
monocentr
studi
review
chart
patient
age
year
admit
intens
care
unit
icu
period
enceph
without
caus
agent
serum
csf
sampl
patient
present
combin
psychiatr
disord
seizur
mening
retrospect
analyz
nmdar
antibodi
six
patient
seven
csf
antinmdar
antibodi
specif
cytopathogen
effect
csf
antibodi
must
look
approxim
fals
neg
result
observ
serum
retrospect
studi
antinmdar
enceph
report
lymphocyt
pleocytosi
case
inconstantli
high
csf
protein
level
usual
gl
csf
oligoclon
band
case
csf
serolog
perform
detect
antinmdarr
antibodi
sensit
specif
perform
serum
antibodi
specif
cytopathogen
effect
immunocytochem
analysi
cell
transfect
express
antigen
interest
usual
perform
eg
nmda
receptor
subunit
test
usual
perform
cell
lineag
human
kidney
hek
cell
author
retrospect
studi
includ
patient
present
pcrconfirm
hsv
enceph
detect
antindmar
igg
iga
igm
antibodi
abl
modifi
vitro
express
synapt
protein
csf
serum
sampl
patient
antibodi
identifi
control
patient
vzv
ev
enceph
author
hypothes
cn
infect
could
trigger
product
antibodi
typic
clinic
present
adem
acut
neurolog
symptom
occur
day
viral
bacteri
infect
follow
vaccin
symptom
vari
combin
conscious
disord
may
lead
coma
sign
focal
case
seizur
case
patient
sometim
present
fever
case
pathophysiolog
probabl
autoimmun
respons
myelin
antigen
trigger
infect
prior
vaccin
patient
present
abnorm
brain
spine
mri
multipl
demyelin
lesion
hypersign
flair
sequenc
usual
show
contrast
enhanc
follow
gadolinium
inject
predefin
diagnost
criteria
differenti
initi
flare
multipl
sclerosi
adem
thu
difficult
retrospect
studi
adem
report
normal
csf
less
case
author
report
moder
pleocytosi
ncmm
predomin
lymphocyt
high
csf
protein
level
gl
intrathec
secret
immunoglobulin
case
adem
multipl
etiolog
postinfecti
etiolog
observ
case
postvaccin
etiolog
although
time
relat
infect
adem
onset
alreadi
proven
pathogen
never
detect
neurolog
specimen
neg
csf
pcr
neg
brain
biopsi
except
case
ebv
mycoplasma
pneumonia
infect
author
literatur
review
present
main
caus
adem
main
viral
caus
measl
adem
patient
per
measl
case
patient
rubella
vzv
adem
patient
per
infect
adem
case
report
end
infect
caus
coronaviru
coxsacki
dengu
ebv
hav
hcv
hiv
mump
parainfluenza
virus
author
report
case
adem
hsv
enceph
case
also
report
bacteri
infect
borrelia
burgdorferi
chlamydophila
sp
legionella
sp
mycoplasma
pneumonia
rickettsia
rickettsii
streptococcu
sp
well
day
follow
vaccin
measl
case
per
vaccin
mump
case
per
vaccin
pertussi
case
per
vaccin
japanes
enceph
case
per
vaccin
diagnost
therapeut
manag
patient
present
enceph
without
document
etiolog
follow
firstlin
test
must
take
consider
potenti
main
caus
infect
diagnost
tool
potenti
treatment
etiolog
investig
must
guid
recent
travel
anim
exposur
age
immunodefici
neurolog
damag
characterist
potenti
extraneurolog
sign
investig
comprehens
physician
keep
mind
possibl
etiolog
specif
intervent
indic
whether
cur
treatment
tuberculosi
enceph
caus
intracellular
bacteria
autoimmun
enceph
prevent
treatment
patient
isol
close
contact
vaccin
benefit
diagnosi
enceph
requir
administr
specif
treatment
also
discontinu
empir
treatment
initi
prescrib
author
declar
compet
interest
